Medimaging Integrated Solution Inc. (TPE:6796)
Taiwan · Delayed Price · Currency is TWD 75.00
+2.20 (3.02%)
At close: Mar 27, 2026
TPE:6796 Revenue
In the year 2025, Medimaging Integrated Solution had annual revenue of 661.39M TWD with 22.72% growth. Medimaging Integrated Solution had revenue of 220.33M in the quarter ending December 31, 2025, with 2.41% growth.
Revenue
661.39M
Revenue Growth
+22.72%
P/S Ratio
4.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 661.39M | 122.47M | 22.72% |
| Dec 31, 2024 | 538.92M | 1.77M | 0.33% |
| Dec 31, 2023 | 537.15M | 35.06M | 6.98% |
| Dec 31, 2022 | 502.09M | 16.22M | 3.34% |
| Dec 31, 2021 | 485.87M | 83.40M | 20.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| Dynamic Medical Technologies | 1.39B |
| WeLeader Biomedical | 1.11B |
| Bioptik Technology Incorporation | 837.19M |
| A Plus Biotechnology | 835.89M |
| Diamond Biotechnology | 698.11M |